Sexual Orientation Is Now a Protected Category
October 07, 2003
Sexual orientation will now be treated as any other protected category in employment litigation under New York State law. After having been proposed without passage for 31 years, the Sexual Orientation Non-Discrimination Act (S. 720/ A. 1971) (SONDA) finally became law on January 16, 2003.
Employers Can Deny Coverage for Certain Infertility Treatments
October 07, 2003
An employer's medical plan that denies coverage for certain female-only infertility procedures does not violate either the Pregnancy Disability Act (PDA) or Title VII of the Civil Rights Act of 1964. The Second Circuit, in a ruling of first impression, concluded that neither are violated.
Property Condition Disclosure Act: The First Published Court Test
October 07, 2003
The Property Condition Disclosure Act (PCDA), which became effective on March 1, 2002, requires a seller of residential real property to deliver to a buyer a Property Condition Disclosure Statement (PCDS) before the buyer signs a binding contract. In <i>Malach v. Chuang, infra</i>, a Richmond County Civil Court judge construed ' for the first time ' the remedy provisions of the statute (R.P.L. sec. 465).
Real Property Law
October 07, 2003
Analysis of the latest cases of interest to your practice.
ONLINE: How to Research Human Organ Damage
October 07, 2003
If your product liability case involves damage to a specific organ, <i>eg,</i> heart damage allegedly caused by the use of fen-phen, professional organizations such as the American College of Cardiology (ACC) may offer some assistance. You can go to the association's Web site (www.acc.org) for information on a number of conditions.
CASE NOTES
October 07, 2003
Highlights of the latest intellectual property cases from around the country.
Daubert: 10 Years Later
October 07, 2003
<i>This is the first of a two-part article. Part two will appear next month.</i> Product liability practitioners must be intimately familiar with the strategy and tactics of challenging expert testimony under Rule 702, Fed. R. Evid., and the so-called <i>Daubert</i> trilogy of cases. Nearly 10 years ago, the United States Supreme Court, in <i>Daubert v. Merrill Dow Pharmaceuticals, Inc.</i>, 509 U.S. 579 (1993), vastly changed the road map for the admission of expert testimony. A body of case law has grown since that decision, providing numerous avenues to challenge admission of expert testimony. Because product liability cases usually rely on expert testimony, <i>Daubert</i> challenges are particularly important in them.
Development
October 07, 2003
The latest rulings you need to know.
